BIOSIMILIARS
Nearly 35-40% of our weightage is in pharma, that story has just begun: Ravi Dharamshi'I cannot rule out a correction or a dip at any point of time but you need to be looking to buy.'- Biocon Q2 net moves up 20% to Rs 89.22 croreBiocon reported 20.26% increase in net profit for the quarter ended September 30 to Rs 89.22 crore on the back of strong sales.
- Load More